Xconomy.com -- One of Seattle’s leading life sciences entrepreneurs, Bruce Carter, is back in the saddle. Carter has agreed to take an active management role as executive chairman of Seattle-based Immune Design, a year after he announced he was retiring as CEO of ZymoGenetics.